A. Escalante

1.1k total citations
14 papers, 776 citations indexed

About

A. Escalante is a scholar working on Rheumatology, Surgery and Physiology. According to data from OpenAlex, A. Escalante has authored 14 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 3 papers in Surgery and 3 papers in Physiology. Recurrent topics in A. Escalante's work include Systemic Lupus Erythematosus Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Orthopedic Infections and Treatments (2 papers). A. Escalante is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Orthopedic Infections and Treatments (2 papers). A. Escalante collaborates with scholars based in United States, Chile and South Korea. A. Escalante's co-authors include Robin L. Brey, Inmaculada del Rincón, Thomas D. Beardmore, Marta Navarrete, Amy R. Saklad, Stephen L. Holliday, Gary Gronseth, David L. McGlasson, L. Miller and Roy W. Haas and has published in prestigious journals such as Neurology, Annals of Oncology and Annals of the Rheumatic Diseases.

In The Last Decade

A. Escalante

13 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Escalante United States	8	549	241	177	129	107	14	776
Gerlof P. T. Bosma Netherlands	14	338 0.6×	164 0.7×	147 0.8×	142 1.1×	104 1.0×	17	614
Marta Vadacca Italy	17	465 0.8×	85 0.4×	295 1.7×	150 1.2×	123 1.1×	49	921
Massimo Borrelli Italy	12	289 0.5×	263 1.1×	86 0.5×	108 0.8×	58 0.5×	27	576
Nancy Futrell United States	9	272 0.5×	232 1.0×	105 0.6×	69 0.5×	95 0.9×	24	854
Steven Dinsmore United States	7	336 0.6×	240 1.0×	219 1.2×	126 1.0×	131 1.2×	10	957
Virgilio Sangalang Canada	10	174 0.3×	212 0.9×	72 0.4×	67 0.5×	75 0.7×	20	562
Kenji P. Fujita United States	12	342 0.6×	590 2.4×	173 1.0×	481 3.7×	178 1.7×	27	1.3k
M. Galeazzi Italy	16	359 0.7×	37 0.2×	202 1.1×	88 0.7×	169 1.6×	63	974
Eva Astrid Jacobsen Norway	12	113 0.2×	221 0.9×	76 0.4×	74 0.6×	139 1.3×	27	539
Patrizia Nencini Italy	17	195 0.4×	323 1.3×	49 0.3×	129 1.0×	64 0.6×	42	876

Countries citing papers authored by A. Escalante

Since Specialization

Citations

This map shows the geographic impact of A. Escalante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Escalante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Escalante more than expected).

Fields of papers citing papers by A. Escalante

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Escalante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Escalante. The network helps show where A. Escalante may publish in the future.

Co-authorship network of co-authors of A. Escalante

This figure shows the co-authorship network connecting the top 25 collaborators of A. Escalante. A scholar is included among the top collaborators of A. Escalante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Escalante. A. Escalante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Fekry, Baharan, Rafael Bravo, A. Escalante, et al.. (2025). Targeting the hepatic circadian clock concomitant with tyrosine kinase inhibition reverses late-stage hepatocellular carcinoma. Cell Reports. 44(11). 116313–116313.

Rha, Sun Young, et al.. (2024). 516MO Zanidatamab (Zani) + chemotherapy (CT) in first-line (1L) human epidermal growth factor receptor 2-positive (HER2+) advanced/metastatic colorectal cancer (mCRC). Annals of Oncology. 35. S436–S437. 3 indexed citations

González, Débora A., Maria Luisa Bianchi, A. Escalante, et al.. (2023). Hyposalivation and periodontal disease as oral non-articular characteristics in rheumatoid arthritis. Clinical Rheumatology. 43(1). 95–102. 3 indexed citations

Rincón, Inmaculada del, et al.. (2004). Lower limb arterial incompressibility and obstruction in rheumatoid arthritis. Annals of the Rheumatic Diseases. 64(3). 425–432. 46 indexed citations

Holliday, Stephen L., et al.. (2003). Validating a computerized neuropsychological test battery for mixed ethnic lupus patients. Lupus. 12(9). 697–703. 48 indexed citations

Brey, Robin L., Stephen L. Holliday, Amy R. Saklad, et al.. (2002). Neuropsychiatric syndromes in lupus. Neurology. 58(8). 1214–1220. 434 indexed citations

Witten, Tarynn M., Inmaculada del Rincón, & A. Escalante. (2000). Modeling the progression of articular erosion in rheumatoid arthritis (RA): Initial mathematical models. Mathematical and Computer Modelling. 31(2-3). 31–38. 7 indexed citations

Brey, Robin L. & A. Escalante. (1998). Neurological manifestations of antiphospholipid antibody syndrome. Lupus. 7(2_suppl). 67–74. 81 indexed citations

Escalante, A. & Thomas D. Beardmore. (1997). Predicting length of stay after hip or knee replacement for rheumatoid arthritis.. PubMed. 24(1). 146–52. 31 indexed citations

10.

Escalante, A., et al.. (1996). Perioperative management of rheumatoid arthritis. Areas of concern for primary care physicians.. PubMed. 99(2). 191–4, 199. 6 indexed citations

11.

Escalante, A., et al.. (1995). A method for scoring the pain map of the McGill pain questionnaire for use in epidemiologic studies. Aging Clinical and Experimental Research. 7(5). 358–366. 36 indexed citations

12.

Escalante, A., L. Miller, & Thomas D. Beardmore. (1993). Resistive exercise in the rehabilitation of polymyositis/dermatomyositis.. PubMed. 20(8). 1340–4. 72 indexed citations

13.

Escalante, A. & Thomas D. Beardmore. (1993). Decreased bone mineral density in HLA-B27 positive members of a family with osteogenesis imperfecta.. PubMed. 20(2). 320–4. 7 indexed citations

14.

Escalante, A., et al.. (1990). [Cobalt therapy in the treatment of Osler-Rendu disease. Apropos of two cases].. PubMed. 39(1). 57–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact